Ohambweni lokuthola isisindo esinempilo, abantu abaningi bazithola behlola izinketho ezingaphezu kokudla nokuzivocavoca. Ukuthuthuka kwesayensi yezokwelapha kwethule imithi engasiza ukuncipha kwesisindo , okunikeza ithemba elisha kulabo abanenkinga yokukhuluphala ngokweqile. Imithi emibili enjalo, i-Wegovy ne-Saxenda, isithole ukunakwa ngokusebenza kwayo. Ukuqonda umehluko nezinzuzo zabo kubalulekile ekwenzeni ukukhetha unolwazi.
Yomibili le mithi ivunyiwe yi-FDA futhi inqunyelwe ukusekela ukwehla kwesisindo kubantu abadala abanokukhuluphala ngokweqile noma abantu abakhuluphele abanezimo zezempilo ezihlobene nesisindo. Njengoba isithakazelo kulokhu kwelashwa sikhula, siyanda nesidingo sokuqonda ukuthi umuthi ngamunye usebenza kanjani nokuthi yimuphi ongase ulungele izidingo zomuntu ngamunye.
I-Wegovy ne-Saxenda imithi emibili ejovwayo eklanyelwe ukusiza ekunciphiseni isisindo, ngayinye inezindawo nezindlela ezihlukile, futhi ukukhetha okulungile kuncike ezicini zezempilo zomuntu siqu kanye nezinjongo ezithile zokunciphisa isisindo.
Ukuqonda i-Wegovy ne-Saxenda
I-Wegovy (semaglutide) kanye ne-Saxenda (liraglutide) bangaphansi kwekilasi lezidakamizwa elaziwa ngokuthi ama-GLP-1 receptor agonists. Balingisa i-hormone glucagon-like peptide-1, edlala indima ekulawuleni ukudla kanye nokudla. Naphezu kokufana kwayo, le mithi inomehluko ohlukile ekwakhekeni kwayo, imithamo, namaza okuphatha.
I-Wegovy iqukethe i-semaglutide, inhlanganisela eyasungulwa ekuqaleni ukwelapha isifo sikashukela sohlobo 2 ngaphansi kwegama lomkhiqizo elithi Ozempic. I-Wegovy yakhelwe ngokukhethekile ukulawula isisindo futhi iphathwa kanye ngesonto ngomjovo. Ukugunyaza kwayo ukwehlisa isisindo kusekelwe ezivivinyweni zomtholampilo ezibonisa ukwehla kwesisindo esikhulu kubahlanganyeli.
Ngakolunye uhlangothi, iSaxenda iqukethe i-liraglutide, ephinde isetshenziselwe ukulawulwa kwe-glycemic kushukela ngaphansi kwegama lomkhiqizo i-Victoza. Ngezinhloso zokwehlisa isisindo, i-Saxenda inqunywa ngethamo eliphezulu futhi ilawulwa nsuku zonke ngomjovo. I-Saxenda yavunywa ngaphambi kwe-Wegovy futhi isisetshenziswe kabanzi iminyaka eminingana.
Umehluko owodwa obalulekile phakathi kwemithi emibili uhlelo lwabo lomthamo. Umjovo we-Wegovy kanye weviki wonke ungase unikeze lula kakhulu uma kuqhathaniswa nemijovo yansuku zonke edingekayo nge-Saxenda. Lo mehluko ungaba nomthelela ekubambeleleni ohlelweni lwemithi kanye nokwaneliseka kwesiguli sonke.
Ukuqonda lo mehluko obalulekile kubalulekile lapho ucubungula le mithi. Izinto ezifana nemvamisa yokudosa, ukujwayelana nokuzijova, kanye nendlela yokuphila kungaba nomthelela ekukhetheni phakathi kwe-Wegovy ne-Saxenda.
Izindlela Zokuthi Zisebenza Kanjani?
Yize yomibili le mithi ingama-agonists e-GLP-1 receptor, ihluka kancane ezakhiweni zayo zamangqamuzana nendlela ewuthinta ngayo umzimba. I-GLP-1 iyihomoni ekhuthaza ukukhiqizwa kwe-insulin, ivimbele ukukhululwa kweglucagon, ibambezele ukuphuma kwesisu, futhi yandise ukusutha—konke lokhu okunomthelela ekwehleni kwesisindo.
I-Wegovy (semaglutide) inohhafu wempilo ende kune-Saxenda (liraglutide), eyivumela ukuthi iphathwe kanye ngesonto. I-Semaglutide ibophezela kumamukeli we-GLP-1 ngokuhlangana okuphezulu, okuholela emiphumeleni evelele kakhulu ekucindezelweni kwesifiso sokudla kanye nokunciphisa ukudla.
I-Saxenda isebenza ngendlela efanayo kodwa idinga ukuphathwa kwansuku zonke ngenxa yesikhathi sayo esifushane sokusebenza. I-Liraglutide iphinde yehlise ijubane ukuphuma kwesisu futhi ithuthukise ukusutha, kepha imiphumela yayo ingase iqine kancane uma iqhathaniswa ne-semaglutide.
Yomibili le mithi ayisizi nje kuphela ekunciphiseni isisindo kodwa futhi inemiphumela emihle ezicini eziyingozi zenhliziyo nemithambo yegazi. Bangathuthukisa umfutho wegazi, amazinga e-cholesterol, nokulawulwa kwe-glycemic, okuzuzisa kakhulu abantu abanezimo zempilo ezihlobene nokukhuluphala.
Ukuqonda ukuthi le mithi isebenza kanjani kungasiza iziguli nabahlinzeki bezempilo benze izinqumo ezinolwazi. Umehluko we-pharmacokinetic phakathi kwe-semaglutide ne-liraglutide ungase ube nomthelela ekusebenzeni kwawo kanye nokufaneleka kwesiguli ngasinye.
Ukusebenza kahle kanye Nesisindo Sokulahlekelwa Kwesisindo
Izivivinyo zomtholampilo zikhombisile ukuthi i-Wegovy ne-Saxenda ziyasebenza ukuncipha kwesisindo uma kuhlangene nokungenelela kwendlela yokuphila njengokudla nokuzivocavoca. Nokho, kunomehluko ophawulekayo enanini lokuncipha kwesisindo elibonwa ngomuthi ngamunye.
Ucwaningo lubonise ukuthi iziguli ezisebenzisa i-Wegovy zingase zehle kakhulu isisindo uma ziqhathaniswa nalezo ezisebenzisa i-Saxenda. Ezivivinyweni zomtholampilo, ababambiqhaza abathatha i-Wegovy balahlekelwe isilinganiso esingaba ngu-15% wesisindo somzimba wabo emasontweni angama-68, kuyilapho labo ababethatha i-Saxenda balahlekelwa cishe ngo-5% kuya ku-10% emasontweni angama-56.
Ukusebenza okukhulu kwe-Wegovy kungase kubangelwe amandla ayo aphezulu kanye nesenzo eside. Ukuncipha okukhulu kwesisindo okuzuzwe nge-Wegovy kube yisici esibalulekile ekuthandeni kwayo okukhulayo phakathi kweziguli ezifuna ukunciphisa umzimba.
Kodwa-ke, imiphumela ngayinye ingahluka ngokusekelwe ezicini ezimbalwa, okuhlanganisa ukunamathela kuhlelo lwemithi, izinguquko zendlela yokuphila, nezimo zempilo yomuntu siqu. Kubalulekile ukuthi iziguli zibeke okulindelwe okungokoqobo futhi zisebenzisane eduze nabahlinzeki bazo bezempilo.
Ekugcineni, nakuba i-Wegovy ingase inikeze ukwehla kwesisindo esikhulu ngokwesilinganiso, i-Saxenda isalokhu iyinketho ephumelelayo, ikakhulukazi kulabo abangase bakhethe ukudosa umthamo wansuku zonke noma ukucatshangelwa kwezempilo okukhethekile okwenza kube ukukhetha okungcono.
Imiphumela Emibi kanye Nokucatshangelwa Kokuphepha
Njengayo yonke imithi, i-Wegovy kanye ne-Saxenda iza nemiphumela engemihle engaba khona iziguli okufanele ziyiqaphele. Imiphumela emibi evamile yayo yomibili imithi ihlanganisa izimpawu zesisu ezifana nokucanuzela kwenhliziyo, ukuhlanza, isifo sohudo, ukuqunjelwa, nobuhlungu besisu.
Le miphumela engemihle ivame ukuvela kakhulu ekuqaleni kokwelashwa futhi ingase yehle njengoba umzimba ujwayela imithi. Ukwenyuka komthamo kancane kancane njengoba kunqunywe umhlinzeki wezempilo kungasiza ekwehliseni le miphumela.
Imiphumela emibi kakhulu ayivamile kodwa ingabandakanya i-pancreatitis, isifo se-gallbladder, nezinkinga zezinso. Yomibili le mithi inesexwayiso mayelana nengozi engaba khona yezimila ze-C-cell yegilo, ngokusekelwe ocwaningweni lwamagundane, nakuba lokhu kungakaze kuqinisekiswe kubantu.
Iziguli ezinomlando womuntu siqu noma womndeni wezinhlobo ezithile zomdlavuza wegilo noma i-multiple endocrine neoplasia syndrome uhlobo 2 akufanele zisebenzise le mithi. Kubalulekile ukuxoxa kahle ngomlando wezokwelapha nomhlinzeki wezempilo ngaphambi kokuqala ukwelashwa.
Ukuqapha ngochwepheshe bezempilo kubalulekile ukuze kuqinisekiswe ukusetshenziswa okuphephile kwale mithi. Ukulandelela okuvamile kungasiza ekulawuleni noma yimiphi imiphumela emibi futhi kulungiswe ukwelashwa njengoba kudingeka.
Ukwenza Ukukhetha Okulungile: I-Wegovy noma i-Saxenda?
Ukukhetha phakathi kwe-Wegovy ne-Saxenda kuhilela ukucabangela izici eziningi, okuhlanganisa ukusebenza kahle, imiphumela engemihle, ukusebenziseka kalula, kanye nezimo zempilo ngazinye.
I-Wegovy ingase ibe inketho ekhethwayo kulabo abafuna ukunciphisa umzimba kanye nokuba lula kokudosa kanye ngeviki. Umthelela wayo obalulekile ekunciphiseni isisindo ungaba isikhuthazo ezigulini eziye zazabalaza nezinye izindlela zokungenelela.
I-Saxenda ingase ifanelekele abantu abakhetha ukujwayela umthamo wansuku zonke noma abangaphendula kangcono ku-liraglutide ngenxa yezizathu zempilo yomuntu siqu. Inephrofayili yokuphepha esungulwe kusukela eminyakeni yokusetshenziswa.
Izindleko kanye nokufakwa komshwalense nakho kungaba nomthelela esinqumweni. Yomibili imithi ingamba eqolo, futhi izinhlelo zomshwalense zingase zibe nezinqubomgomo zokukhava ezihlukene. Iziguli kufanele zithintane nabahlinzeki bazo bomshwalense futhi ngokunokwenzeka zifune izinhlelo zokusiza isiguli uma kudingeka.
Ekugcineni, isinqumo kufanele senziwe ngokubambisana nomhlinzeki wezokunakekelwa kwempilo ongahlola umlando wezokwelapha womuntu, imigomo yokulahlekelwa isisindo, kanye nezintandokazi zokuncoma imithi efanelekile kakhulu.
Isiphetho
Sengiphetha, i-Wegovy ne-Saxenda zinikeza izinketho zezokwelapha eziphumelelayo zokulahlekelwa isisindo, ngayinye enezinzuzo zayo. Ukusebenza okuphakeme kwe-Wegovy kanye nokuthatha umthamo wamasonto onke kukwenza kube ukukhetha okukhangayo kwabaningi, kuyilapho ukusetshenziswa okumisiwe kwe-Saxenda kanye nohlobo lwansuku zonke kungase kuhambisane nabanye.
Ukuqonda umehluko phakathi kwale mithi kubalulekile ezigulini eziqala uhambo lwazo lokulahlekelwa isisindo. Ngokucabangela izici ezinjengokusebenza kahle, imiphumela emibi, izintandokazi zomthamo, kanye nezimo zezempilo zomuntu siqu, abantu bangasebenzisana nabahlinzeki babo bezempilo ukuze bakhethe inketho evumelana kangcono nezidingo zabo.
Ukwehla kwesisindo kuwuhambo lomuntu siqu futhi ngokuvamile oluyinselele. Ngokutholakala kwemithi efana ne-Wegovy ne-Saxenda, kunamathuluzi amaningi kunangaphambili okusekela abantu ngabanye ekufinyeleleni izinjongo zabo zezempilo. Ukuxhumana okuvulekile nabasebenzi bezempilo kanye nokuzinikela ekushintsheni indlela yokuphila kuyizici ezibalulekile zempumelelo.
FAQ
Umbuzo: Ngingakwazi yini ukushintsha ngisuke e-Saxenda ngiye e-Wegovy uma ngingaboni imiphumela engiyifunayo?
IMP: Yebo, kodwa noma yiziphi izinguquko emithini kufanele zenziwe ngaphansi kokuqondisa komhlinzeki wezempilo.
Umbuzo: Ingabe i-Wegovy ne-Saxenda ikhokhelwa umshwalense?
IMP: Ukuhlinzekwa kuyehluka ngohlelo lomshwalense; kufanele uhlole nomhlinzeki wakho ukuze uqonde izinzuzo zakho.
Umbuzo: Ingabe ngidinga ukulandela ukudla okukhethekile ngenkathi ngithatha le mithi?
A: Ukudla okunekhalori encishisiwe kanye nokuzivocavoca umzimba okwandisiwe kuyanconywa ukuze kuthuthukiswe ukusebenza kahle kwayo yomibili imithi.
Umbuzo: Ngingahlala isikhathi esingakanani ku-Wegovy noma e-Saxenda?
IMPENDULO: Ubude besikhathi sokwelashwa kufanele bunqunywe umhlinzeki wakho wokunakekelwa kwezempilo ngokusekelwe ekuqhubekeni kwakho kokulahlekelwa isisindo kanye nesimo sezempilo.
Umbuzo: Kwenzekani uma ngigeja umthamo womuthi wami?
A: Landela imiyalelo enikezwe umhlinzeki wakho wokunakekelwa kwezempilo noma umhlahlandlela wemithi; xhumana nomhlinzeki wakho uma ungaqiniseki.
Q: Kuthiwani uma ngiguliswa yi-Wegovy (semaglutide)?
A: Ngempela, eminye imitholampilo ibike amacala eziguli ezibhekana nokungezwani komzimba ku-semaglutide. Uma uguliswa yi-semaglutide, ungase ucabangele i-OTESALY FAT-X njengenye indlela. I-OTESALY FAT-X isebenzisa i-acetyl hexapeptide-39, esebenza ngendlela ehlukile kuma-agonists e-GLP-1 kodwa ibonise imiphumela ethembisayo ekulawuleni ukudla nokulawula isisindo. Amakhasimende ethu amaningi abelane ngokuthi ngenkathi engezwani ne-semaglutide, athole imiphumela emihle kakhulu nge-OTESALY FAT-X ngaphandle kokungezwani komzimba. Kuziguli ezingase zingabekezeleli i-semaglutide, i-OTESALY FAT-X inikeza inketho eyingqayizivele nephumelelayo.
Q: I-Wegovy ne-Saxenda zibiza kakhulu. Ingabe zikhona ezinye izindlela ezithengekayo?
IMP: Uma ufuna inketho engabizi kakhulu yokwesekwa kokulawulwa kwesisindo, i-OTESALY FAT-X kufanele icatshangelwe. Uma kuqhathaniswa nama-agonists e-GLP-1, i-OTESALY FAT-X inikeza inani elingabizi kakhulu futhi iye yasetshenziswa kabanzi ezimakethe zomhlaba, ikakhulukazi e-US naseYurophu, lapho ithole impendulo eyakhayo kubasebenzisi. I-OTESALY FAT-X isebenza kahle ekusekeleni ukuphathwa kwesisindo, ikwenze kube ukukhetha okufanele kulabo abanezinkinga zesabelomali abasafuna ukwesekwa okusebenzayo kwesisindo. Uma unentshisekelo, zizwe ukhululekile ukwenza kanjalo xhumana nathi ukuze ufunde kabanzi mayelana nezinketho zokuthenga kanye namalungiselelo afanelekile wokuthumela.
